Patents by Inventor Priya Dayananth

Priya Dayananth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-8 level as a determinant of responsivity of a cancer to treatment
    Patent number: 9229008
    Abstract: The present application includes methods for using IL-8 as a biomarker for, e.g., tumor size, for example, during course of treatment with an anti-cancer agent such as an ERK inhibitor.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: January 5, 2016
    Assignee: MERCK SHARP & DOHME CORP.
    Inventors: Ahmed A. Samatar, Brian Long, Priya Dayananth, Diane Levitan, Marsha Smith
  • IL-8 biomarker for monitoring cancer treatment with certain ERK inhibitors
    Patent number: 8586543
    Abstract: The present application includes methods for using IL-8 as a biomarker for, e.g., tumor size, for example, during course of treatment with an anti-cancer agent such as an ERK inhibitor.
    Type: Grant
    Filed: August 17, 2009
    Date of Patent: November 19, 2013
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Ahmed A. Samatar, Brian Long, Priya Dayananth, Diane Levitan, Marsha Smith
  • IL-8 BIOMARKER FOR MONITORING CANCER TREATMENT
    Publication number: 20110288102
    Abstract: The present application includes methods for using IL-8 as a biomarker for, e.g., tumor size, for example, during course of treatment with an anti-cancer agent such as an ERK inhibitor.
    Type: Application
    Filed: August 17, 2009
    Publication date: November 24, 2011
    Applicant: Schering Corporation
    Inventors: Ahmed A. Samatar, Brian Long, Priya Dayananth, Diane Levitan, Marsha Smith